I really do believe this Chinese partnership is a major development. I am happy to see this. As it now is clear how Keppra and Gluco will be produced. I always said the Toronto facility was not the right fit for producing high volume, low cost drugs. But a plant in China, sure is...
Also, this development probably opens doors to other markets- Namely China and Asia. Last time I checked lots of people over there...
Certainly this is big news, that should translate to revenue soon.
Andrew did mention that there were planning to expand to other markets and there was a great deal of interest from China. Hi didn't provide any details though.
I think it might be very exciting news. I'd love to see some official PR soon.
News 
Market Data 
Discover 
